C78-58250-73081
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-03-31
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
-
2021-04-21
Survey response — day 21, dose 2MedDRA: Headache — Feeling: FairFree text: Occasional sharp pain in a specific part of my head/skull.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
- 2021-05-05
-
2021-05-12
Survey response — day 42, dose 2MedDRA: Office visit, Postmenopausal haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: I have had post menopausal bleeding. In my 10 years since menopause this has never happened. · Healthcare visit (other): Went to Gyne office for exam.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-01
Survey response — 3 months, dose 2MedDRA: Hysterectomy, Postmenopausal haemorrhage, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Post menopausal bleeding and had to have hysterscopy surgery and D&C.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-24
- 2021-09-29
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-12 | Unsuccessful | |
| 2021-07-01 | Unsuccessful |
Free text
Release 7 — day 21, dose 2
Symptoms: Occasional sharp pain in a specific part of my head/skull.
Release 8 — day 42, dose 2
Symptoms: I have had post menopausal bleeding. In my 10 years since menopause this has never happened.
Healthcare visit (other): Went to Gyne office for exam.
Release 9 — 3 months, dose 2
Symptoms: Post menopausal bleeding and had to have hysterscopy surgery and D&C.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hysterectomy | ✓ | ✓ | ✓ |
| SD | Postmenopausal haemorrhage | ✓ | ✓ | ✓ |
| SD | Uterine dilation and curettage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release